Literature DB >> 29203994

An Overview of the Current Management of Bilobar Colorectal Liver Metastases.

Rebecca K L Griggs1, Samir Pathak1, Graeme Poston2.   

Abstract

Bilobar colorectal liver metastases (BCRLM) present a challenging scenario for liver surgeons globally. The following article aims to provide an overview of the different strategies which may be utilised in order to successfully manage advanced BCRLM.

Entities:  

Keywords:  Ablation; Bilobar; Colorectal liver metastases; Portal vein embolisation; Resection; Two-stage hepatectomy

Year:  2017        PMID： 29203994      PMCID： PMC5705516          DOI： 10.1007/s13193-017-0686-6

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


  55 in total

1.  Living donor right liver lobes: preoperative CT volumetric measurement for calculation of intraoperative weight and volume.

Authors:  Arne-Jörn Lemke; Martin Julius Brinkmann; Thomas Schott; Stefan Markus Niehues; Utz Settmacher; Peter Neuhaus; Roland Felix
Journal:  Radiology       Date:  2006-07-25       Impact factor: 11.105

2.  Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.

Authors:  Chusilp Charnsangavej; Bryan Clary; Yuman Fong; Axel Grothey; Timothy M Pawlik; Michael A Choti
Journal:  Ann Surg Oncol       Date:  2006-09-01       Impact factor: 5.344

3.  Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.

Authors:  Kosuke Mima; Toru Beppu; Akira Chikamoto; Yuji Miyamoto; Shigeki Nakagawa; Hideyuki Kuroki; Hirohisa Okabe; Hiromitsu Hayashi; Yasuo Sakamoto; Masayuki Watanabe; Ken Kikuchi; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2012-09-01       Impact factor: 3.402

4.  Two-stage hepatectomy for multiple bilobar colorectal liver metastases.

Authors:  M Narita; E Oussoultzoglou; D Jaeck; P Fuchschuber; E Rosso; P Pessaux; E Marzano; P Bachellier
Journal:  Br J Surg       Date:  2011-06-28       Impact factor: 6.939

Review 5.  Oncologic resection for malignant tumors of the liver.

Authors:  Shefali Agrawal; Jacques Belghiti
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

6.  Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period.

Authors:  Tatjana Gruber-Rouh; Nagy N N Naguib; Katrin Eichler; Hanns Ackermann; Stephan Zangos; Jörg Trojan; Martin Beeres; Marc Harth; Boris Schulz; Nour-Eldin Nour-Eldin A; Thomas J Vogl
Journal:  Int J Cancer       Date:  2013-09-03       Impact factor: 7.396

Review 7.  Resection of Liver Metastases in Colorectal Cancer in the Era of Expanding Systemic Therapy.

Authors:  Robert P Jones; Graeme J Poston
Journal:  Annu Rev Med       Date:  2016-09-28       Impact factor: 13.739

8.  Factors influencing the natural history of colorectal liver metastases.

Authors:  R Stangl; A Altendorf-Hofmann; R M Charnley; J Scheele
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

9.  Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment.

Authors:  Kun-Ming Chan; Jy-Ming Chiang; Chen-Fang Lee; Ming-Chin Yu; Wei-Chen Lee; Jinn-Shiun Chen; Jeng-Yi Wang
Journal:  World J Surg Oncol       Date:  2011-12-30       Impact factor: 2.754

10.  Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.

Authors:  Dieter C Broering; Christian Hillert; Gerrit Krupski; Lutz Fischer; Lars Mueller; Eike G Achilles; Jan Schulte am Esch; Xavier Rogiers
Journal:  J Gastrointest Surg       Date:  2002 Nov-Dec       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.